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Abstract
Background: The gap between research and practice limits utilization of relevant, progressive and empirically
validated strategies in substance abuse treatment.
Methods: Participants included substance abuse treatment programs from the Northeastern United States.
Structural equation models were constructed with agency level data to explore two outcome variables: adoption
of practice guidelines and assessment tools at two points in time; models also included organizational, staffing and
service variables.
Results: In 1997, managed care involvement and provision of primary care services had the strongest association
with increased use of assessment tools, which, along with provision of counseling services, were associated with a
greater use of practice guidelines. In 2001, managed care involvement, counseling services and being a stand-
alone drug treatment agency were associated with a greater use of assessment tools, which was in turn related to
an increase in the use of practice guidelines.
Conclusions: This study provides managers, clinicians and policy-makers with a framework for understanding
factors related to the adoption of new technologies in substance abuse treatment.
Background
A “widespread unease with the slow pace of adoption of
research findings” has developed in the United States field
of alcohol and drug treatment [1]. Simultaneously, the
complexity of treatment needs, and pressure for high qual-
ity services for fewer treatment dollars, has increased the
need for educated and highly skilled clinicians. However,
the “hodgepodge” of funding streams and lack of formal
training in the treatment of alcohol and drug disorders at
the graduate level prevent some counselors and agencies
from adopting innovations [2]. One such area in which this
gap exists is the adoption of practice guidelines that incor-
porate the use of standardized assessment tools and empiri-
cally supported treatments for substance abuse treatment.
Science-based Practice Tools and Guidelines
Variations in practice styles, inappropriate and unneces-
sary use of services, uncertain health outcomes and risk
management have all been linked to the increased need
for outcome and effectiveness research and application
of science-based practice strategies and guidelines [3]. In
contrast, others assert that practice guidelines and man-
ualized treatment tools may “constrain clinical decision-
making” [4], and often are based on questionable meth-
ods and limited findings. According to Weisz and col-
leages, the proliferation of collectively produced
guidelines represents an effort to increase order and
coherence through convention, standards, and regula-
tion of the rapidly expanding and heterogenous medical
domain [5]. Thus, rising health care costs and standardi-
zation of performance and outcome measurement have
increased the development of assessment tools, manua-
lized treatments, and evidence-based strategies available
for substance abuse treatment. Practice guidelines that
incorporate empirically supported treatments are
described as systematically developed statements which
assist decision-making and are suggestive, rather than
prescriptive, in terms of identifying and providing effica-
cious treatment recommendations [3,4,6,7].
Currently, there are several practice guidelines for
substance abuse treatment. The American Psychiatric
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agement: (1) the establishment and maintenance of a
therapeutic relationship, (2) continued monitoring of the
patient’s clinical status, (3) management of states of
intoxication and withdrawal, (4) reduction of morbidity,
(5) facilitation of treatment plan adherence and provi-
sion of educational materials, and finally (6) diagnosis
and treatment of psychiatric disorders [8]. Another
important practice guideline or decision-making algo-
rithm is the American Society of Addiction Medicine
(ASAM) level of care criteria. ASAM published this first
set of placement criteria in 1991 [9], and they have
revised and improved upon the model with the second
edition, the Patient Placement Criteria (PPC-2R), pub-
lished in April 2001 [10]. As one of the most widely
used guidelines for the placement and continued stay
and subsequent discharge of substance abuse patients,
the ASAM criteria is a common acronym across settings
in substance abuse service delivery. In regular use within
a number of treatment settings, the ASAM PPC-2R pro-
vides criteria for five levels of care for adults and adoles-
cents: Level 0.5, Early Intervention; Level I, Outpatient
Treatment; Level II, Intensive Outpatient/Partial Hospi-
talization; Level III, Residential/Inpatient Treatment; and
Level IV, Medically-Managed Intensive Inpatient Treat-
ment. Data collected from all 51 single state authorities
(SSAs) for substance abuse treatment suggest that
ASAM is in widespread use (T.R., unpublished data).
SSA representatives from each of the 50 states and
Washington DC were interviewed in 2009. SSA repre-
sentatives used a Likert-type scale ("1 = not at all” to
“5 = extensively”) to rate the extent to which their state
had implemented ASAM. Nearly all SSAs (86.2%) have
implemented ASAM at least “slightly”, with mean
nationwide implementation of 4.4 (out of 5) in 2009.
Another comprehensive effort in establishing practice
guidelines for substance abuse treatment has been made
by the United States Substance Abuse and Mental
Health Services Administration’s Center for Substance
Abuse Treatment’s (CSAT) Treatment Improvement
Protocol (TIP) series. Guidelines for treatment are based
on an extensive review of the literature and are available
in easy to access manuals for specific populations, diag-
nostic cohorts or co-occurring disorders. Finally, the
American Psychological Association took an even
broader view related to practice guidelines and devel-
oped criteria for the development and evaluations of
such guidelines to support clinicians and organizations
as they make decisions about implementation of practice
guidelines [11]. Thus, there are several key decision-
making guidelines and resources across the service
delivery system.
Research supports the real-world efficacy of following
research-derived practice guidelines in substance abuse
treatment. Two examples are opiate substitution treat-
ment for heroin dependence [12] and buprenorphine for
acute heroin detoxification [13]. Providing managers,
clinicians and policy-makers with a framework for
understanding organizational, staffing and service deliv-
ery factors related to the adoption of new technologies
is critical in an era of increased accountability. To better
conceptualize these constructs several models exploring
diffusion have been developed and preliminary studies
are emerging in the substance abuse treatment
literature.
Models of Adoption and Diffusion
Simpson’s conceptual framework suggests that institu-
tional/personal readiness and organizational dynamics
predict exposure, adoption, implementation, and routine
use of innovative practices including practice guidelines
[14]. The model delineates interrelationships among
readiness for change, training, staff attributes, and insti-
tutional resources and support. Successful technology
transfer efforts make use of interpersonal contacts (con-
sultants, researchers on location, multi-site workshops)
[1]. Thomas and colleagues [15] offer a framework
based on classical diffusion theory [16] and posit that
environmental factors and clinicians affect the adoption
of new technologies or strategies. This model includes
interactions between clinician characteristics (age, train-
ing, experience), organizational or practice characteris-
tics (philosophy, mission, financing, structure), qualities
of the new technology, the patient population, and the
treatment environment (state policies, market environ-
ment, disease prevalence). These models posit that orga-
nizational characteristics and staffing patterns may
influence the adoption of new innovations.
Practitioners with more formal education, and with
higher social status, tend to have a more favorable out-
look regarding change [17]. Adopters also are more
likely to seek out information and have national profes-
sional contacts [17]. Organizational structure also can
affect adoption of new practice and guidelines. Struc-
tural characteristics may include the organization’s loca-
tion, size, accreditation, and overall mission [18]. The
mix of funding streams, and the related requirements
for each entity that programs derive reimbursement or
revenue from, is also a major structural or organiza-
tional factor influencing use of specific practices. Agen-
cies that have managed care contracts are likely to be
encouraged to standardize their practices and use of
tools as the managed care companies seek to match
requirements and reports across their networks. Organi-
zational dynamics, climate, and the readiness to change
are also integral components of the adoption of new
technologies or practices [14]. Finally, Fixsen and collea-
gues developed a cycle of core components
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training, consultation, and coaching (e.g., providing
supervision, feedback, and emotional support) to frame
the dynamic process of successful implementation [19].
Staff factors also may determine whether a new assess-
ment tool or practice guideline is adopted into clinical
practice. An examination of staff attitudes from the Uni-
ted States National Institute on Drug Abuse (NIDA)
Clinical Trials Network indicated that personal beliefs
regarding treatment affected clinical practice and the
adoption of new interventions [20]. A survey of physi-
cians’ attitudes toward clinical guidelines or algorithms
reported that physicians believed that guidelines were
utilized more for cost containment purposes and less for
quality improvement [21]. A more recent survey
reported that substance abuse treatment professionals
tend to have positive attitudes toward manualized treat-
ment (e.g., beliefs that following a manual helps thera-
pists evaluate and improve clinical skills, and enhances
therapeutic outcomes) [22]. Further, increases in knowl-
edge of the effectiveness of a medication and organiza-
tional support influence the use of a medication to treat
substance dependence [15,23]. There is, however, a pau-
city of work about the specific organizational qualities
that affect implementation of standardized assessments
and practice guidelines.
Examination of utilization of practice guidelines and
standardized tools may provide insight regarding agency
and counselor factors associated with successful adop-
tion for treatment planning and adaptations in service
delivery. This study examines the organizational, staff-
ing, and service characteristics that predict utilization of
science-based practice tools and practice guidelines in
outpatient substance abuse treatment programs.
Methods
T h eN e wE n g l a n dO u t p a t i e n tS u r v e y[ 2 4 ]a s s e s s e dt h e
routine use of ASAM criteria for patient placement, use
of treatment manuals (CSAT TIP documents; NIDA
Therapy Manuals for Drug Addiction) and use of assess-
ment tools such as the Addiction Severity Index [25]
and the Beck Depression Inventory [26]. Organizational
characteristics were assessed including agency size,
funding sources, educational level, number of staff in
recovery, and agency mission. Surveys completed in
1997, 1999, and 2001 assessed staff and agency charac-
teristics, current practices,a n di n n o v a t i o n su s e di n
treatment. The 1997 and 2001 cohorts were examined
in this paper.
Participants
All licensed outpatient substance abuse treatment pro-
grams in the six New England states (CT, NH, ME, MA,
RI, & VT) were included in the study sample. After
accounting for programs that merged, moved or chan-
ged names, and programs operating multiple facilities,
the list of potential outpatient centers included 341
organizations in 1997 [27]. Introductory letters were
m a i l e d ,f o l l o w e db yas u r v e yp a c k e tm a i l e do n em o n t h
later. Follow-up calls were placed to all treatment pro-
grams to confirm receipt of the packet, answer ques-
tions, draw attention to the study, and emphasize the
importance of a timely response. The call concluded
with scheduling an appointment with a research assis-
tant for a telephone interview. Lost surveys were
replaced and missed appointments were rescheduled as
needed to ensure a representative sample. The full sam-
ple of respondents in 1997 (n = 281 agencies, 83% com-
pletion rate) consisted of directors or their
representatives at freestanding substance abuse facilities
(34%; n = 98), community mental health services (31%;
n = 88), hospitals and integrated health care systems
(18%; n = 51), and social service agencies and other
types of programs (15%; n = 44).
The 2001 survey used similar sample selection includ-
ing only outpatient programs that were licensed. Some
agencies may have closed or merged, although study
methods simply noted agencies that were no longer in
the database without determination of the specific
changes in status of facilities. The full sample of respon-
dents in 2001 (n = 246 agencies, 72% completion rate)
consisted of directors or their representatives at free-
standing substance abuse facilities (26%; n = 64), com-
munity mental health services (20%; n = 50), hospitals
and integrated health care systems (21%; n = 51), and
social service agencies and other types of programs
(33%; n = 81).
Variables
Organizational characteristics and staffing were
hypothesized to influence adoption of new technolo-
gies. All variables included in the structural models are
transformations of items from the New England Out-
patient Survey from 1997 and 2001 and are listed in
Table 1. Models included three organizational variables
(size of agency, managed care involvement, and being
a freestanding alcohol and drug treatment program)
and two staffing variables (staff recovery status and
education level). Two service variables were included
(counseling and ancillary services, and medical and
medication services). The two outcome variables were
use of practice guidelines and use of assessment and
screening tools. The practice guidelines variable was a
sum of the levels of care tools (e.g., use of ASAM Cri-
teria, use of state modified placement criteria), treat-
ment manuals, and protocols that are used in the
organization. The screeningo ra s s e s s m e n tt o o l sm e a -
sure was the sum of the standardized assessments
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Beck Depression Inventory.
Data Analysis
Structural equation modeling (SEM) with manifest (i.e.,
observed) variables was the primary analytic method.
Standard regression models do not allow more than one
criterion variable in the same model, and do not allow
examination of mediating relationships between predic-
tors. Structural equation modeling allows for complex
interrelationships to be modeled simultaneously.
A maximum likelihood estimation method was used
to estimate parameters using the CALIS module in the
SAS Program [28-30]. Models were estimated for the
1997 and 2001 cohorts, respectively, with similar pat-
terns expected for each time, but also allowing for dif-
ferences over time. To identify the most parsimonious
model, paths with non-significant regression weights or
paths that did not contribute to a good model fit were
dropped. Because SEM cannot handle missing data, only
cases with complete data were available for analysis. A
listwise deletion technique of cases with missing data
resulted in 188 cases available for the 1997 model and
144 cases for the 2001 model. The variables in SEM
included only manifest constructs. For example, “medi-
cal and medication services” is a construct of number of
medical services and number of medication services (see
Table 1). Because some manifest variables were con-
structed as sums of two or more indicators, and because
some item wording changed between the two adminis-
trations, a standardization technique (z transformation)
eliminated differences in the item metrics. Z tests of
two proportions examined differences in binary variables
and differences between means were assessed with
ANOVAs. Some of these means were counts of vari-
ables. The F test is relatively robust and does not gener-
ate bias in response to violation of parametric
assumptions provided that sample sizes are not overly
discrepant.
Results
Table 2 presents variable means and percentages from
the full sample of respondents (1997 N = 281; 2001 N =
246). Actual sample sizes for each variable are presented
in parentheses in each cell of Table 2. Significant
increases were observed between 1997 and 2001 in the
use of any practice guidelines, and in the mean number
of medication and medical services offered (see Table
2). The ASAM Patient Placement Criteria was the most
widely used level of care tool among participating out-
patient treatment programs, with nearly half of the pro-
grams reporting the use of ASAM at both time points.
Table 1 Variable descriptions
Variable Name Variable Description
Organizational Items
Size of Agency Number of unduplicated client visits over the period of one week in all outpatient units in the organization.
Managed Care Involvement A 0-2 scale: one point was added if the agency received Medicaid managed care, and another point was added
if the agency received private or commercial managed care.
Freestanding Clinic (non-
hospital based)
A dichotomous variable that assigned a 1 if the primary mission was “substance abuse only facility” and a 0 for
the rest of the clinics (hospital, primary care clinic or other clinic).
Staffing Items
Counselor Education Level Counselor education was measured with a weighted sum of the proportion of counselors with Doctoral, Masters,
Bachelors, Associate or no degree: i.e., Educational Level = 4*(% of counselors with Ph.D.’s) + 3*(% of counselors
with master’s) + 2*(% of counselors with bachelor’s) + 1*(% with less than a bachelor’s). Higher scores indicate
higher educational training for the staff.
Staff in Recovery The percentage of staff at self-identified as in recovery.
Services
Counseling and Ancillary
Services
This item assessed the range of counseling services offered at the clinic. This included both counseling (i.e.,
psychotherapy, assessment, group therapy, psycho-educational groups, intensive outpatient, day and evening
programs and case management support services) and support services (child care, employment counseling and
transportation). This variable is scored as the sum of the services offered at each clinic.
Medical and Medication
Services
This item assessed the range of medical (i.e., primary care, HIV testing, TB testing, OB/GYN, and pregnancy
testing) and medication services (naltrexone, disulfiram, methadone, LAAM, TB medication, HIV medication,
psychotropic, anti-depressants and anti-psychotics). This variable is the sum of each of the services offered at
each clinic.
Outcomes
Use of Assessment Tools This was the sum of the standardized assessments for addiction that are used in the clinic (e.g., ASI, ADAD, DUSI,
POSIT, LOCI, and RATE) as well as the psychiatric instruments used (e.g., SCID, GAF).
Use of Practice Guidelines This was measured by items that assessed whether practice guidelines or other treatment protocols are used in
the agency which included guidelines on medication management, depression, eating disorders, psychosis,
alcohol, cocaine and heroin use disorders.
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more likely to use ASAM (1997 = 63%; 2001 = 55%),
followed by community mental health agencies (1997 =
55%; 2001 = 55%) and hospitals (1997 = 41%; 2001 =
52%). Use of ASAM placement criteria did not differ
based on clinic size, licensure, or level of education.
The most common standardized assessment tool in
the participating outpatient treatment programs was the
Addiction Severity Index (1997 = 33%; 2001 = 29%).
The most common mental health assessment was the
Global Assessment of Functioning (1997 = 79%; 2001 =
84%), followed by the Structured Clinical Interview for
Diagnosis (SCID), (1997 = 32%; 2001 = 40%). Many pro-
grams used assessments created specifically by their staff
to assess addiction and mental health (1997 = 100%;
2001 = 86%).
The structural equation model for the 1997 cohort
is presented in Figure 1 and is based on 188 complete
Table 2 Comparisons of differences between the two time points of measurement
Variable
a 1997 (N = 281)
c 2001(N = 246)
c
Mean SD Mean SD Sig. tests P-value
% with Managed Care Involvement
b 77.07% (266) - 73.73% (217) z = -.659 n.s.
% using Practice Guidelines
b 66.65% (278) - 75.33% (223) - z = 1.852 p < .10
% using Practice ASAM
b 44.96% (278) - 43.94% (217) - z = -.133 n.s
% of Staff in Recovery
c 32.00% (266) 30.11 27.30% (221) 29.27 F(1,486) = 2.98 n.s.
Counseling Services (Number of) 4.93 (278) 1.52 5.17 (223) 1.38 F(1,499) = 3.18 n.s.
Medication Services (Number of) 0.49 (278) 0.99 2.82 (223) 1.94 F(1,499) = 302.58 p < .0001
Medical Services (Number of) 0.51 (278) 1.31 2.54 (223) 1.21 F(1,499) = 509.03 p < .0001
Ancillary Services (Number of) 0.54 (278) 0.94 0.69 (223) 0.89 F(1,499) = 3.48 n.s.
Clients served per week 119.00 (272) 238.03 189.80 (221) 925.36 F(1,490) = 1.47 n.s.
a Value in parentheses is the n for each variable.
b This designates a binomial variable. The percentage is the number of clinics that have this characteristic. Test statistic used was a z test of two proportions.
c This is a mean of the percent of staff in recovery for each clinic.
Figure 1 Time 1 Path Model of Predictors of Practice Guidelines and Practice Tools.
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indices (X
2 = 33.23, df = 23, p = .0771; CFI = .9341,
RMSEA = .0558). No residuals were greater than 2.22.
Although not temporal, the models represent relation-
ships among variables. In this first model, programs that
have greater involvement with managed care and pro-
grams that offer more medical and medication services
are more likely to use assessment and screening tools.
Extending these relationships, the model also captures the
relationships between the increased use of screening and
assessment tools, and provision of counseling and ancil-
lary services, and the greater use of practice guidelines.
Programs with more managed care involvement were
less likely to identify themselves as a freestanding addic-
tion treatment programs (as compared to multi-service,
hospital, or medical based clinics). Programs with more
involvement from managed care were also more likely
to have staff with advanced degrees, as opposed to free-
standing programs that employed more staff in recovery.
Larger agencies were more likely to provide a range of
treatment options including offering medications, medi-
cal services and additional ancillary or support services.
A similar model with organizational, staff, and service
delivery variables was constructed for the 2001 cohort
and is based on 144 complete observations (see Figure 2).
Eliminating non-significant paths and high residuals
reduced this model to a parsimonious description of the
interrelationships of these variables. The data fit the
model well (X
2 = 28.17, df = 20, p = .1055; CFI = .9596,
RMSEA = .0439) and no residuals were greater than 2.50.
Managed care involvement also was influential in this
second model. Freestanding clinics or treatment pro-
grams were less likely to be supported by managed care
funding. Managed care also was associated with higher
counselor education levels and use of assessment and
screening tools. Similar to the 1997 model, agencies that
were larger in size again offered more medical services,
medications and a greater range of counselling and ancil-
lary services.
Discussion
The results of this study suggest that the two outcomes,
use of standardized assessment tools and use of practice
guidelines, are interdependent. In the first model (Time
1), managed care involvement, and provision of medical
care services and use of medications had the strongest
association with increased use of standardized assess-
ment tools. Use of assessment tools and offering coun-
seling and ancillary services was then associated with
greater use of practice guidelines. In the second model
Figure 2 Time 2 Path Model of Predictors of Practice Guidelines and Practice Tools.
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ciated with increased use of assessment tools, as was
being a stand-alone drug treatment agency. The rela-
tionship between provision of counseling and ancillary
services had a stronger association with assessment tools
in this model, but the relationship between the use of
assessment tools and a greater use of practice guidelines
remained strong in the second model. Thus, programs
that offer a larger range of services (i.e., medical, ancil-
lary or wrap around, medication and counseling) and
have strong relationships with or receive funding from
managed care entities, appear to be more likely to adopt
standardized assessments and practice guidelines or
algorithms.
In terms of clinical staff and their impact on adoption,
programs that were free-standing or non-hospital based
were also more likely to have a greater number of staff
in recovery and providers with fewer years of education.
Managed care involvement was also associated with hav-
ing more staff with higher education.
It is also interesting to note that the majority of agen-
cies created their own assessments/intakes, or possibly
used a mix of standardized assessments, suggesting a
legacy of program tools that may not be updated fre-
quently. This range of eclectic assessment practices may
also reflect dissatisfaction with, or a lack of knowledge
about validated assessment tools. Thus the models from
this study provide data for state, county and community
policy makers to consider when allocating resources,
planning trainings, and implementing targeted systemic
interventions.
Adoption of Evidence-Based Practices
Overall, research thus far suggests limited use of prac-
tice guidelines in community-based substance abuse
treatment. To better understand why this implementa-
tion or such clinical decision guides is slow, organiza-
tional, environmental and staff factors must be
examined. To date, services research suggests that the
decision to adopt new practices is often influenced by
the demands of the funding entities and institutional
structures [14,15]. Further, providers that are most likely
to adopt new practices tend to have more formal educa-
tion, come from a higher social status, and have a more
favorable outlook regarding change [17]. These early
adopters are also more likely to take the initiative to
seek out information and have a greater number of
national professional contacts [17]. Clinicians indicate
that they are more open to new strategies when those
practices clearly improve services and outcomes, are
consistent with their philosophy of treatment, and are
supported with training that includes observation, prac-
tice, supervision, and feedback prior to full adoption
[31-33]. Organizational structures and practices (e.g.,
funding mechanisms, agency mission, and data manage-
ment systems) also impact the use of innovations within
substance abuse treatment programs. Thus, both indivi-
dual treatment providers and agency level or organiza-
tional characteristics influence the implementation of
new practices including practice guidelines and the use
of assessment and screening tools [15,18,19]. The results
of this study correspond with this implementation
science and classical diffusion theory literature. Funding
mechanisms (involvement with managed care), treat-
ment philosophy (counseling and use of ancillary ser-
vices), and staff characteristics were associated with
greater implementation of practice guidelines and
assessment tools. The ASAM patient placement guide-
lines and the ASI assessment tool were widely used and
were considered best practices by the participating out-
patient treatment programs.
Interestingly, although having greater involvement with
managed care was associated with specific staff character-
istics as well as with use of assessment tools and practice
guidelines, in this project the level of counselor education
in the programs and the number of staff in recovery was
not directly associated with greater use of practice guide-
lines. Although other research has found that education
is associated with more positive opinions about evidence-
based practices [32] and greater acceptance of innovation
[17], previous investigations were based on attitudes sur-
veys with treatment center staff. The current data came
from a survey of treatment center directors and not a
direct assessment of counselors or staff. Methodological
differences may explain the difference in findings. It may
also be that use of assessment tools and practices guide-
lines present a greater level of controversy and challenge
for providers. According to Miller, Zweben and Johnson
[34], retraining providers with established habits and
experiences is both challenging and time consuming. The
use of standardized assessment tools and practice guide-
lines requires considerable training and supervision.
Autonomy also has been associated with increased satis-
faction and commitment to the organization [35], thus
providers may value independence in decision-making
and they may also not have access to the necessary train-
ing and supervision related to assessment and the use of
guidelines. Finally, staff may have felt constrained by
guidelines and may not have perceived any clinical or
organizational benefit with their implementation in their
treatment programs. Thus, the findings from this study
may differ somewhat from previous studies that suggest
counselor characteristics predict adoption of new prac-
tices due to methods (i.e., response of agency directors),
the amount of training and supervision required to use
standardized tools and guidelines, as well the constraint
or lack of autonomy that counselors may resist when
using use tools/guidelines.
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important relationship between agency size, counseling
and ancillary services, and use of practice guidelines and
standardized assessment tools. Larger agencies offered
more counseling and ancillary services which contribu-
ted to the use of practice guidelines and assessment/
screening tools. Integration of primary care and mental
health with substance abuse treatment offers increased
access to a range of providers, medications, and inde-
pendence from government funding which provides
leverage for change and flexible, progressive decision-
making for the organization [36,37]. Large agencies that
offer a wider range of services have the resources to
purchase assessment instruments, provide training, con-
duct organizational change processes, and flex their
resources in a fashion that is necessary for the imple-
mentation of standardized practice guidelines. Consis-
tent with the literature, participation in ancillary service
delivery appears to connect programs with other com-
munity providers, exposing managers and counselors to
diagnostic tools and procedures outside their immediate
organization [38]. Applying this literature base to speci-
fic clinical practices, including use of standardized
assessment tools and practice guidelines, provides
greater understanding of these factors and their dynamic
and interdependent impact on diffusion of innovations
Limitations
This study had a number of limitations. The sample
included six New England states, which may have lim-
ited generalizability to the rest of the United States.
New England is a region with high managed care pene-
tration and a high degree of public sector treatment
agencies which may not be characteristic of the rest of
the country. In addition, slight wording changes in the
surveys between the two data collection points created
some restrictions regarding the type of longitudinal ana-
lysis that could be used (i.e., models are not dependent
time 1 to time 2). Had the models been able to be
dependent, statistical tests would likely have been more
sensitive. However, because not all clinics were repre-
sented in each sample, this was not possible and is a
limitation of the study. Missing data imputation is not
used with structural equation modeling, thus a listwise
deletion technique results in parsimonious models based
on cases with complete data available for analysis.
Finally, although data were collected in 2001, dissemina-
tion of these findings is important because they are con-
sistent with the literature confirming the difficulties
changing practice patterns and disseminating research
findings. The study results may also be used for com-
parison with future assessment that evaluates the use of
practice guidelines.
Conclusions
This study provides managers, clinicians and policy-
makers with a framework for understanding factors related
to the adoption of new technologies in substance abuse
treatment. Findings from this study suggest that increasing
the use of evidence-based practices or tools may require
provider and organizational change efforts as well as sys-
tems wide interventions that result in revised policies,
changes in contract language and specific detailed descrip-
tions of procedures and expectations. State substance
abuse authorities (SSAs), regulatory and funding entities
clearly play a significant role in clinical practice and the
quality of addiction treatment services. Expanding the fra-
mework from provider and organizational factors to
include state/county and city policy makers, current
change efforts such as the Robert Wood Johnson Advan-
cing Recovery Initiative are emerging. This intervention
partners the state authority with providers and other sta-
keholders to address systems wide change aimed at
increasing the use of evidence-based practices. Through
this type of collaboration, and with appropriate state
administrative data, research literature, and leadership,
policy makers will be able to make informed decisions that
impact the quality of addiction services.
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